BioTissue to develop cell-lined vessel graft
This article was originally published in Clinica
Executive Summary
Two German tissue engineering companies, BioTissue Technologies and Cell-Lining, are to co-develop and market an artificial cardiac vessel graft whose lining is seeded with autologous vessel wall cells to prevent the occurrence of atherosclerosis.